AzTrials
AzTrials

Depressive DisorderNCT06668701

Evaluation of the Naturalistic User Experience of the Website "Ich Bin Alles"

An observational study of Depressive Disorder and Depression, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Using a multi-method approach, the aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles". This website offers evidence-based information about the symptoms, causes, course, treatment, and prevention of youth depression. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
"ich bin alles"
Type of treatment
Medical device
How many people
494 participants
Where
1 siteGermany
Study dates
20 Jun 2024to 1 Apr 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: users of the website "ich bin alles"

Who may be able to join

  • 40 seconds website-use

Who cannot join

  • no exclusion criteria

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • LMU University Hospital

    Munich, Bavaria, 80336

Other trials in Germany

About this study

Official title: Evaluation of the Naturalistic User Experience of the Website "Ich Bin Alles" - an Information Platform for Children and Adolescents With and Without Depression and Their Relatives

Using a multi-method approach, the aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles". This website offers evidence-based information about the symptoms, causes, course, treatment, and prevention of youth depression. Another aim of this study is to determine whether the desired target groups of the website can be reached.

Read the detailed description

Depressive disorders are among the most common mental illnesses in children and adolescents and were already on the rise before the COVID-19 pandemic. This trend has been further exacerbated by the pandemic. Depression in adolescents is associated with particularly serious consequences, such as school and social problems, increased risk of suicide and impaired mental health in adulthood. If depression persists, the risk of chronification increases and continuous school attendance or continuation of vocational training is more difficult. The longer a depressive illness is not (effectively) treated, the lower the likelihood of remission and the higher the risk of chronification with further depressive episodes over the course of the illness. Although there are effective forms of treatment, in Germany only around 12% of adolescents with increased symptoms of depression seek professional treatment. The main barriers for adolescents to seek professional help include, for example, individual factors (low knowledge of mental disorders), social factors (e.g., perceived social stigmatisation) and systemic and structural barriers (e.g., limited access to professional help). In order to meet the need for action in a timely manner that meets the needs of the target group, the Department of Child and Adolescent Psychiatry of the Hospital of the LMU Munich and the Beisheim Foundation launched the innovative digital information portal "ich bin alles" ("I am everything"; www.ich-bin-alles.de) on depression and mental health in youth in 2021. Due to a sharp increase in online health information in recent years, the quality of this information and information portals has increasingly become the centre of attention. A review of the quality of mental health information websites found that many of the websites had shortcomings in terms of transparency, presentation and accuracy of content. These limitations were confirmed in a more recent study of depression websites. The comprehensibility of the content is also often limited, especially for users with a lower level of education and/or health literacy.

Due to the high relevance of comprehensively evaluating web-based information services on mental health and mental illness, the aim of this study is to use established methods to learn more about the visitors of "ich bin alles" and their user experience. This study will build on the approach of previous studies on website evaluation, which usually follow a multi-method approach: The evaluation of website analyses using tools such as Matomo; as well as an online questionnaire. The study is intended to provide clues as to whether the "ich bin alles" information platform is a useful and trustworthy source of information for the target groups. The information obtained is of central importance for potential adaptations and optimizations of the "ich bin alles" website. Another aim of this study is to determine whether "ich bin alles" can actually reach its desired target groups. The results of the data collection also provide an important basis for future approaches aimed at informing children, young people and their parents about mental health issues and mental illness in a way that is appropriate for the target group.

Being tested
"ich bin alles"
Keywords
depression, prevention, web-based, adolescents, depression literacy, user experience, acceptance
Medical subject headings
Depressive Disorder, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "ich bin alles"Device

    The web-based information platform "ich bin alles" (www-ich-bin-alles.de) on depression and mental health in childhood and adolescence was developed by the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy of the LMU Munich Hospital together with the Prof. Otto Beisheim Foundation. It is aimed at children and adolescents with depression, healthy children and adolescents and parents. The project focuses on education, prevention, support and destigmatisation through the transfer of evidence-based knowledge.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The characteristics of the people who are interested in "ich bin alles" (i.e. the users) - Assessed via self-designed questionnaire

    Measured: post (40 seconds after Website-use)

  2. Perception of the users of website content - Assessed via WEB-CLIC-S

    Measured: post (40 seconds after Website-use)

  3. Perceived Website Usability - Assessed via Perceived Website Usability - German

    Measured: post (40 seconds after Website-use)

  4. Visual Aesthetics of Website - Assessed via Visual Aesthetics of Website Inventory - Short

    Measured: post (40 seconds after Website-use)

  5. Overall impression - assessed via a single item (school grade)

    Measured: post (40 seconds after Website-use)

  6. Intentions to act - Assessed via Scale assessing the intention to revisit the website

    Measured: post (40 seconds after Website-use)

Secondary outcomes (5)
  1. specific data collected for "ich bin alles" with Matomo

    Title of the pages accessed (page title)

    Measured: 45 months (from launch of the website until anticipated study completion)

  2. specific data collected for "ich bin alles" with Matomo

    Location of the users: Country, region, city, approximate latitude and longitude (geolocation)

    Measured: 45 months (from launch of the website until anticipated study completion)

  3. specific data collected for "ich bin alles" with Matomo

    Number of the website users

    Measured: 45 months (from launch of the website until anticipated study completion)

  4. specific data collected for "ich bin alles" with Matomo

    How the users accessed the website (e.g. Google search or Social Media link)

    Measured: 45 months (from launch of the website until anticipated study completion)

  5. specific data collected for "ich bin alles" with Matomo

    How much time the users spend on the website

    Measured: 45 months (from launch of the website until anticipated study completion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2024
  2. Study start20 Jun 2024
  3. Primary completion1 Apr 2026
  4. Study completion1 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
494 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06668701
Sponsor's protocol ID
24-0201 KB
Status last verified
Sep 2026
First submitted
27 Sep 2024
Last updated
21 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Depressive Disorder and Depression, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The characteristics of the people who are interested in "ich bin alles" (i.e. the users) - Assessed via self-designed questionnaire (time frame: post (40 seconds after Website-use)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in